Design of PLGA Based Nanoparticles for Imaging Guided Applications

Autores
Mariano, Rodolfo Nicolás; Alberti, Diego Javier; Cutrin, Juan Carlos; Geninatti Crich, Simonetta; Aime, Silvio
Año de publicación
2014
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
An amphiphilic Gd(III) complex has been efficiently loaded in polylactic-co-glycolic acid nanoparticles (PLGA-NPs) to yield a novel, high sensitive magnetic resonance imaging (MRI) contrast agent for imaging guided drug delivery applications. As the Gd(III) complex is soluble in organic solvents, the nanoparticles were prepared as oil/water emulsions. PLGA-NPs were stable, in buffer, for more than 1 week without any release of the incorporated agents. The millimolar relaxivity of the Gd(III) complex incorporated in the particles (140 nm diameter) was of 21.7 mM(-1) s(-1) at 21.5 MHz, a value that is about 5 times higher than that observed with the commercially available contrast agents used in clinic. The relaxometric efficiency of these particles resulted inversely proportional to the particle size measured by dynamic light scattering. The high stability and sensitivity of PLGA-NPs allowed their accumulation in vivo in murine melanoma xenograft as shown in the corresponding MR images. Once loaded with drug and contrast agents, PLGA nanoparticles can be proposed as efficient theranostic MRI agents.
Fil: Mariano, Rodolfo Nicolás. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina
Fil: Alberti, Diego. Università di Torino; Italia
Fil: Cutrin, Juan Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina
Fil: Geninatti Crich, Simonetta. Università di Torino; Italia
Fil: Aime, Silvio. Università di Torino; Italia
Materia
Gd(Iii) Complexes
Mri
Contrast Agents
Imaging Guided Therapy
Plga
Nanoparticles
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/30786
Acceder
id CONICETDig_ac2413df8798e5a80ccb0134220ef3fc
oai_identifier_str oai:ri.conicet.gov.ar:11336/30786
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Design of PLGA Based Nanoparticles for Imaging Guided ApplicationsMariano, Rodolfo NicolásAlberti, Diego JavierCutrin, Juan CarlosGeninatti Crich, SimonettaAime, SilvioGd(Iii) ComplexesMriContrast AgentsImaging Guided TherapyPlgaNanoparticleshttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3https://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3An amphiphilic Gd(III) complex has been efficiently loaded in polylactic-co-glycolic acid nanoparticles (PLGA-NPs) to yield a novel, high sensitive magnetic resonance imaging (MRI) contrast agent for imaging guided drug delivery applications. As the Gd(III) complex is soluble in organic solvents, the nanoparticles were prepared as oil/water emulsions. PLGA-NPs were stable, in buffer, for more than 1 week without any release of the incorporated agents. The millimolar relaxivity of the Gd(III) complex incorporated in the particles (140 nm diameter) was of 21.7 mM(-1) s(-1) at 21.5 MHz, a value that is about 5 times higher than that observed with the commercially available contrast agents used in clinic. The relaxometric efficiency of these particles resulted inversely proportional to the particle size measured by dynamic light scattering. The high stability and sensitivity of PLGA-NPs allowed their accumulation in vivo in murine melanoma xenograft as shown in the corresponding MR images. Once loaded with drug and contrast agents, PLGA nanoparticles can be proposed as efficient theranostic MRI agents.Fil: Mariano, Rodolfo Nicolás. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; ArgentinaFil: Alberti, Diego. Università di Torino; ItaliaFil: Cutrin, Juan Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; ArgentinaFil: Geninatti Crich, Simonetta. Università di Torino; ItaliaFil: Aime, Silvio. Università di Torino; ItaliaAmerican Chemical Society2014-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/30786Mariano, Rodolfo Nicolás; Alberti, Diego Javier; Cutrin, Juan Carlos; Geninatti Crich, Simonetta; Aime, Silvio; Design of PLGA Based Nanoparticles for Imaging Guided Applications; American Chemical Society; Molecular Pharmaceutics; 11; 11; 9-2014; 4100-41061543-8384CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://pubs.acs.org/doi/abs/10.1021/mp5002747info:eu-repo/semantics/altIdentifier/doi/10.1021/mp5002747info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-22T11:31:01Zoai:ri.conicet.gov.ar:11336/30786instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-22 11:31:02.051CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Design of PLGA Based Nanoparticles for Imaging Guided Applications
title Design of PLGA Based Nanoparticles for Imaging Guided Applications
spellingShingle Design of PLGA Based Nanoparticles for Imaging Guided Applications
Mariano, Rodolfo Nicolás
Gd(Iii) Complexes
Mri
Contrast Agents
Imaging Guided Therapy
Plga
Nanoparticles
title_short Design of PLGA Based Nanoparticles for Imaging Guided Applications
title_full Design of PLGA Based Nanoparticles for Imaging Guided Applications
title_fullStr Design of PLGA Based Nanoparticles for Imaging Guided Applications
title_full_unstemmed Design of PLGA Based Nanoparticles for Imaging Guided Applications
title_sort Design of PLGA Based Nanoparticles for Imaging Guided Applications
dc.creator.none.fl_str_mv Mariano, Rodolfo Nicolás
Alberti, Diego Javier
Cutrin, Juan Carlos
Geninatti Crich, Simonetta
Aime, Silvio
author Mariano, Rodolfo Nicolás
author_facet Mariano, Rodolfo Nicolás
Alberti, Diego Javier
Cutrin, Juan Carlos
Geninatti Crich, Simonetta
Aime, Silvio
author_role author
author2 Alberti, Diego Javier
Cutrin, Juan Carlos
Geninatti Crich, Simonetta
Aime, Silvio
author2_role author
author
author
author
dc.subject.none.fl_str_mv Gd(Iii) Complexes
Mri
Contrast Agents
Imaging Guided Therapy
Plga
Nanoparticles
topic Gd(Iii) Complexes
Mri
Contrast Agents
Imaging Guided Therapy
Plga
Nanoparticles
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv An amphiphilic Gd(III) complex has been efficiently loaded in polylactic-co-glycolic acid nanoparticles (PLGA-NPs) to yield a novel, high sensitive magnetic resonance imaging (MRI) contrast agent for imaging guided drug delivery applications. As the Gd(III) complex is soluble in organic solvents, the nanoparticles were prepared as oil/water emulsions. PLGA-NPs were stable, in buffer, for more than 1 week without any release of the incorporated agents. The millimolar relaxivity of the Gd(III) complex incorporated in the particles (140 nm diameter) was of 21.7 mM(-1) s(-1) at 21.5 MHz, a value that is about 5 times higher than that observed with the commercially available contrast agents used in clinic. The relaxometric efficiency of these particles resulted inversely proportional to the particle size measured by dynamic light scattering. The high stability and sensitivity of PLGA-NPs allowed their accumulation in vivo in murine melanoma xenograft as shown in the corresponding MR images. Once loaded with drug and contrast agents, PLGA nanoparticles can be proposed as efficient theranostic MRI agents.
Fil: Mariano, Rodolfo Nicolás. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina
Fil: Alberti, Diego. Università di Torino; Italia
Fil: Cutrin, Juan Carlos. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina
Fil: Geninatti Crich, Simonetta. Università di Torino; Italia
Fil: Aime, Silvio. Università di Torino; Italia
description An amphiphilic Gd(III) complex has been efficiently loaded in polylactic-co-glycolic acid nanoparticles (PLGA-NPs) to yield a novel, high sensitive magnetic resonance imaging (MRI) contrast agent for imaging guided drug delivery applications. As the Gd(III) complex is soluble in organic solvents, the nanoparticles were prepared as oil/water emulsions. PLGA-NPs were stable, in buffer, for more than 1 week without any release of the incorporated agents. The millimolar relaxivity of the Gd(III) complex incorporated in the particles (140 nm diameter) was of 21.7 mM(-1) s(-1) at 21.5 MHz, a value that is about 5 times higher than that observed with the commercially available contrast agents used in clinic. The relaxometric efficiency of these particles resulted inversely proportional to the particle size measured by dynamic light scattering. The high stability and sensitivity of PLGA-NPs allowed their accumulation in vivo in murine melanoma xenograft as shown in the corresponding MR images. Once loaded with drug and contrast agents, PLGA nanoparticles can be proposed as efficient theranostic MRI agents.
publishDate 2014
dc.date.none.fl_str_mv 2014-09
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/30786
Mariano, Rodolfo Nicolás; Alberti, Diego Javier; Cutrin, Juan Carlos; Geninatti Crich, Simonetta; Aime, Silvio; Design of PLGA Based Nanoparticles for Imaging Guided Applications; American Chemical Society; Molecular Pharmaceutics; 11; 11; 9-2014; 4100-4106
1543-8384
CONICET Digital
CONICET
url http://hdl.handle.net/11336/30786
identifier_str_mv Mariano, Rodolfo Nicolás; Alberti, Diego Javier; Cutrin, Juan Carlos; Geninatti Crich, Simonetta; Aime, Silvio; Design of PLGA Based Nanoparticles for Imaging Guided Applications; American Chemical Society; Molecular Pharmaceutics; 11; 11; 9-2014; 4100-4106
1543-8384
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://pubs.acs.org/doi/abs/10.1021/mp5002747
info:eu-repo/semantics/altIdentifier/doi/10.1021/mp5002747
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv American Chemical Society
publisher.none.fl_str_mv American Chemical Society
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846781910109388800
score 12.982451

Publicaciones similares